CEFUROXIME PANPHARMA 750 mg, powder for solution for injection (IM-IV) 10 bottles
Active ingredients: Cefuroxime, Cefuroxime sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection10 bottlesintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFUROXIME PANPHARMA 750 mg, poudre pour solution injectable (IM-IV)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 flacon(s) en verre de 789 mg
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jan 2002
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67941295CIP73574842CIP133400935748423Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFUROXIME SODIQUEpoudre | 789 mg · un flacon | SA |
| CÉFUROXIMEpoudre | 750 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.